Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 11
2003 4
2004 9
2005 11
2006 14
2007 12
2008 18
2009 21
2010 15
2011 24
2012 20
2013 16
2014 10
2015 8
2016 8
2017 9
2018 7
2019 9
2020 10
2021 1
2022 4
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Travoprost/timolol.
Hoy SM, Keam SJ, Keating GM. Hoy SM, et al. Drugs Aging. 2006;23(7):587-97; discussion 598-9. doi: 10.2165/00002512-200623070-00005. Drugs Aging. 2006. PMID: 16930087 Review.
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. ...Travoprost/timol …
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprisi …
Travoprost/timolol fixed combination.
Herceg M, Noecker R. Herceg M, et al. Expert Opin Pharmacother. 2008 Apr;9(6):1059-65. doi: 10.1517/14656566.9.6.1059. Expert Opin Pharmacother. 2008. PMID: 18377347 Review.
The fixed combination eye drop, Duotrav (travoprost 0.004% and timolol maleate 0.5%), has recently been introduced into the market. ...Studies selected for review compared efficacy and side-effect profile of fixed combination travoprost/timolol …
The fixed combination eye drop, Duotrav (travoprost 0.004% and timolol maleate 0.5%), has recently been introduced into …
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.
Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K. Li T, et al. Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31. Ophthalmology. 2016. PMID: 26526633 Free PMC article. Review.
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs were as follows: bimatoprost 5.61 (4.94; 6.29), latanoprost 4.85 (4.24; 5.46), travoprost 4.83 (4.12; 5.54), levobunolol 4.51 (3.85; 5.2 …
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs wer …
Travoprost 0.004%/timolol 0.5% fixed combination.
Noecker RJ, Awadallah NS, Kahook MY. Noecker RJ, et al. Drugs Today (Barc). 2007 Feb;43(2):77-83. doi: 10.1358/dot.2007.43.2.1032058. Drugs Today (Barc). 2007. PMID: 17353945 Review.
Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrated the efficacy and safety of this medication used once daily for the treatment of open-angle glaucoma and ocular hypertension. …
Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies ha …
Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.
Denis P. Denis P. Expert Opin Pharmacother. 2011 Feb;12(3):463-71. doi: 10.1517/14656566.2011.551007. Expert Opin Pharmacother. 2011. PMID: 21254951 Review.
INTRODUCTION: many patients with glaucoma require multiple medications for adequate disease control. This review summarizes the efficacy and safety of the travoprost/timolol fixed combination in lowering intraocular pressure in eyes with glaucoma. ...The safety of …
INTRODUCTION: many patients with glaucoma require multiple medications for adequate disease control. This review summarizes the efficacy and …
Travoprost.
Waugh J, Jarvis B. Waugh J, et al. Drugs Aging. 2002;19(6):465-71; discussion 472-3. doi: 10.2165/00002512-200219060-00005. Drugs Aging. 2002. PMID: 12149052 Review.
Intraocular travoprost 0.004% once daily was significantly more effective at reducing intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension than placebo or timolol 0.5% twice daily and was at least as effective as latanoprost 0.005% …
Intraocular travoprost 0.004% once daily was significantly more effective at reducing intraocular pressure (IOP) in patients with ope …
The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Guven Yilmaz S, Degirmenci C, Karakoyun YE, Yusifov E, Ates H. Guven Yilmaz S, et al. Int Ophthalmol. 2018 Aug;38(4):1425-1431. doi: 10.1007/s10792-017-0601-8. Epub 2017 Jun 14. Int Ophthalmol. 2018. PMID: 28616797 Clinical Trial.
PURPOSE: To evaluate the effect of bimatoprost/timolol maleate fixed combination (BTFC), latanoprost/timolol maleate fixed combination (LTFC), and travoprost/timolol maleate fixed combination (TTFC) on 24-h intraocular pressure (IO …
PURPOSE: To evaluate the effect of bimatoprost/timolol maleate fixed combination (BTFC), latanoprost/timolol maleate …
Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.
Nakano T, Mizoue S, Fuse N, Iwase A, Matsumoto S, Yoshikawa K. Nakano T, et al. Clin Ophthalmol. 2016 Dec 20;11:55-61. doi: 10.2147/OPTH.S120639. eCollection 2017. Clin Ophthalmol. 2016. PMID: 28053501 Free PMC article.
BACKGROUND: We have shown a decrease in mean intraocular pressure (IOP) by switching to travoprost/timolol fixed combination (TTFC) in subjects receiving prostaglandin analogue (PGA) monotherapy and requiring additional medication in a previous report. ...IOP reduct …
BACKGROUND: We have shown a decrease in mean intraocular pressure (IOP) by switching to travoprost/timolol fixed combination ( …
Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
Nakano T, Mizoue S, Fuse N, Iwase A, Matsumoto S, Yoshikawa K. Nakano T, et al. Adv Ther. 2015 Sep;32(9):823-37. doi: 10.1007/s12325-015-0246-9. Epub 2015 Sep 30. Adv Ther. 2015. PMID: 26424331 Free PMC article. Clinical Trial.
INTRODUCTION: The efficacy of lowering intraocular pressure (IOP) and safety of switching to travoprost/timolol fixed combination ophthalmic solution (Duotrav(), Alcon Laboratories, Inc., Fort Worth, TX, USA) in patients with primary open-angle glaucoma, normal tens …
INTRODUCTION: The efficacy of lowering intraocular pressure (IOP) and safety of switching to travoprost/timolol fixed combinat …
The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.
Holló G, Chiselita D, Petkova N, Cvenkel B, Liehneova I, Izgi B, Berta A, Szaflik J, Turacli E, Stewart WC. Holló G, et al. Eur J Ophthalmol. 2006 Nov-Dec;16(6):816-23. doi: 10.1177/112067210601600606. Eur J Ophthalmol. 2006. PMID: 17191187 Clinical Trial.
PURPOSE: To compare the efficacy and safety of timolol maleate 0.5% versus brinzolamide 1% when added to travoprost 0.004% in patients with ocular hypertension or primary open-angle glaucoma. ...RESULTS: Ninety-seven patients on brinzolamide had a baseline di …
PURPOSE: To compare the efficacy and safety of timolol maleate 0.5% versus brinzolamide 1% when added to travoprost 0.0 …
235 results